Publications

1. Dube S, Errazuriz I, Cobelli C, Basu R, Basu A. Assessment of insulin action on carbohydrate metabolism: physiological and non-physiological methods. Diabet Med. 2013 Jun; 30(6):664-70. 2324779
   View PubMed
2. Winnick JJ, Ramnanan CJ, Saraswathi V, Roop J, Scott M, Jacobson P, Jung P, Basu R, Cherrington AD, Edgerton DS. Effects of 11 beta-hydroxysteroid dehydrogenase-1 inhibition on hepatic glycogenolysis and gluconeogenesis. Am J Physiol Endocrinol Metab. 2013 Apr; 304(7):E747-56. 2320793
   
3. Dalla Man C, Piccinini F, Basu R, Basu A, Rizza RA, Cobelli C. Modeling hepatic insulin sensitivity during a meal: validation against the euglycemic hyperinsulinemic clamp. Am J Physiol Endocrinol Metab. 2013 Apr; 304(8):E819-25. 2324472
   
4. Basu R, Barosa C, Jones J, Dube S, Carter R, Basu A, Rizza RA. Pathogenesis of prediabetes: role of the liver in isolated fasting hyperglycemia and combined fasting and postprandial hyperglycemia. J Clin Endocrinol Metab. 2013 Mar; 98(3):E409-17. Epub 2013 Jan 23. 2298899
   View PubMed
5. Basu A, Kudva YC, Basu R. GPR40 modulators: new kid on the block. Diabetes Care. 2013 Feb; 36(2):185-7. 2307518
   View PubMed
6. Manohar C, Levine JA, Nandy DK, Saad A, Dalla Man C, McCrady-Spitzer SK, Basu R, Cobelli C, Carter RE, Basu A, Kudva YC. The effect of walking on postprandial glycemic excursion in patients with type 1 diabetes and healthy people. Diabetes Care. 2012 Dec; 35(12):2493-9. Epub 2012 Aug 08. 2290866
   View PubMed
7. Short KR, Irving BA, Basu A, Johnson CM, Nair KS, Basu R. Effects of type 2 diabetes and insulin on whole-body, splanchnic, and leg protein metabolism. J Clin Endocrinol Metab. 2012 Dec; 97(12):4733-41. Epub 2012 Oct 02. 2273991
   View PubMed
8. Abdelmoneim SS, Hagen ME, Mendrick E, Pattan V, Wong B, Norby B, Roberson T, Szydel T, Basu R, Basu A, Mulvagh SL. Acute hyperglycemia reduces myocardial blood flow reserve and the magnitude of reduction is associated with insulin resistance: a study in nondiabetic humans using contrast echocardiography. Heart Vessels. 2012 Nov 23. [Epub ahead of print] 2285780
   View PubMed
9. Kehlenbrink S, Koppaka S, Martin M, Relwani R, Cui MH, Hwang JH, Li Y, Basu R, Hawkins M, Kishore P. Elevated NEFA levels impair glucose effectiveness by increasing net hepatic glycogenolysis. Diabetologia. 2012 Nov; 55(11):3021-8. Epub 2012 Jul 31. 2281387
   View PubMed
10. Saad A, Dalla Man C, Nandy DK, Levine JA, Bharucha AE, Rizza RA, Basu R, Carter RE, Cobelli C, Kudva YC, Basu A. Diurnal pattern to insulin secretion and insulin action in healthy individuals. Diabetes. 2012 Nov; 61(11):2691-700. Epub 2012 Jun 29. 2284673
    View PubMed
11. Bush NC, Basu R, Rizza RA, Nair KS, Khosla S, Jensen MD. Insulin-mediated FFA suppression is associated with triglyceridemia and insulin sensitivity independent of adiposity. J Clin Endocrinol Metab. 2012 Nov; 97(11):4130-8. Epub 2012 Aug 29. 2267977
    View PubMed
12. Keenan DM, Basu R, Liu Y, Basu A, Bock G, Veldhuis JD. Logistic model of glucose-regulated C-peptide secretion: hysteresis pathway disruption in impaired fasting glycemia. Am J Physiol Endocrinol Metab. 2012 Aug 1; 303(3):E397-409. Epub 2012 Jun 05. 2261700
    View PubMed
13. Jensen MD, Nielsen S, Gupta N, Basu R, Rizza RA. Insulin clearance is different in men and women. Metabolism. 2012 Apr; 61(4):525-30. Epub 2011 Oct 13. 2199646
    View PubMed
14. Wehrwein EA, Curry TB, Basu A, Rizza RA, Basu R, Joyner MJ. Do the carotid bodies modulate hypoglycemic counterregulation and baroreflex control of blood pressure in humans? Adv Exp Med Biol. 2012; 758:129-35. 2278391
    View PubMed
15. Manesso E, Toffolo GM, Basu R, Rizza RA, Cobelli C. Modeling nonsteady-state metabolism from arteriovenous data. IEEE Trans Biomed Eng. 2011 May; 58(5):1253-9. Epub 2010 Dec 03. 2167011
    View PubMed
16. Basu R, Peterson J, Rizza R, Khosla S. Effects of physiological variations in circulating insulin levels on bone turnover in humans. J Clin Endocrinol Metab. 2011 May; 96(5):1450-5. Epub 2011 Feb 16. 2147345
    View PubMed
17. Curry TB, Roberts SK, Basu R, Basu A, Schroeder D, Joyner MJ, Miles JM. Gastric bypass surgery is associated with near-normal insulin suppression of lipolysis in nondiabetic individuals. Am J Physiol Endocrinol Metab. 2011 Apr; 300(4):E746-51. Epub 2011 Feb 08. 2155581
    View PubMed
18. Koutsari C, Basu R, Rizza RA, Nair KS, Khosla S, Jensen MD. Nonoxidative free fatty acid disposal is greater in young women than men. J Clin Endocrinol Metab. 2011 Feb; 96(2):541-7. Epub 2010 Dec 01. 2129756
    View PubMed
19. Basu R, Barosa C, Basu A, Pattan V, Saad A, Jones J, Rizza R. Transaldolase exchange and its effects on measurements of gluconeogenesis in humans. Am J Physiol Endocrinol Metab. 2011 Feb; 300(2):E296-303. Epub 2010 Nov 09. 2123293
    View PubMed
20. Wehrwein E, Basu R, Basu A, Curry T, Rizza R, Joyner MJ. Erratum to "Hyperoxia blunts counterregulation during hypoglycemia in humans: possible role for the carotid bodies?" by Erica A Wehrwein, Rita Basu, Ananda Basu, Timothy B Curry, Robert A Rizza, and Michael J Joyner(doi:10.1113/jphysiol.2010.197491). J Physiol. 2010 Dec 13. [Epub ahead of print] 2135931
    View PubMed
21. Wehrwein EA, Basu R, Basu A, Curry TB, Rizza RA, Joyner MJ. Hyperoxia blunts counterregulation during hypoglycaemia in humans: possible role for the carotid bodies? J Physiol. 2010 Nov 15; 588(Pt 22):4593-601. Epub 2010 Oct 04. 2118572
    View PubMed
22. Basu A, Basu R, Pattan V, Rizza RA, Jensen MD. Meal fat storage in subcutaneous adipose tissue: comparison of pioglitazone and glipizide treatment of type 2 diabetes. Obesity (Silver Spring). 2010 Oct; 18(10):2058-60. Epub 2010 Jun 10. 2101904
    View PubMed
23. Bock G, Dalla Man C, Micheletto F, Basu R, Giesler PD, Laugen J, Deacon CF, Holst JJ, Toffolo G, Cobelli C, Rizza RA, Vella A. The effect of DPP-4 inhibition with sitagliptin on incretin secretion and on fasting and postprandial glucose turnover in subjects with impaired fasting glucose. Clin Endocrinol (Oxf). 2010 Aug; 73(2):189-96. Epub 2009 Dec 18. 2109378
    View PubMed
24. Edgerton DS, Basu R, Ramnanan CJ, Farmer TD, Neal D, Scott M, Jacobson P, Rizza RA, Cherrington AD. Effect of 11 beta-hydroxysteroid dehydrogenase-1 inhibition on hepatic glucose metabolism in the conscious dog. Am J Physiol Endocrinol Metab. 2010 May; 298(5):E1019-26. Epub 2010 Feb 16. 1989137
    View PubMed
25. Campioni M, Toffolo GM, Basu R, Rizza RA, Cobelli C. MINIMAL MODEL ASSESSMENT OF HEPATIC INSULIN EXTRACTION DURING AN ORAL TEST FROM STANDARD INSULIN KINETIC PARAMETERS. Am J Physiol Endocrinol Metab. 2009 Aug 11. [Epub ahead of print] 1968281
    View PubMed
26. Basu R, Chandramouli V, Schumann W, Basu A, Landau BR, Rizza RA. Additional evidence that transaldolase exchange, isotope discrimination during the triose-isomerase reaction, or both occur in humans: effects of type 2 diabetes. Diabetes. 2009 Jul; 58(7):1539-43. Epub 2009 Apr 14. 1937442
    View PubMed
27. Basu A, Dalla Man C, Basu R, Toffolo G, Cobelli C, Rizza RA. Effects of type 2 diabetes on insulin secretion, insulin action, glucose effectiveness, and postprandial glucose metabolism. Diabetes Care. 2009 May; 32(5):866-72. Epub 2009 Feb 05. 1920434
    View PubMed
28. Henderson GC, Dhatariya K, Ford GC, Klaus KA, Basu R, Rizza RA, Jensen MD, Khosla S, O'Brien P, Nair KS. Higher muscle protein synthesis in women than men across the lifespan, and failure of androgen administration to amend age-related decrements. FASEB J. 2009 Feb; 23(2):631-41. Epub 2008 Sep 30. 1915592
    View PubMed
29. Basu R, Basu A, Grudzien M, Jung P, Jacobson P, Johnson M, Singh R, Sarr M, Rizza RA. Liver is the site of splanchnic cortisol production in obese nondiabetic humans. Diabetes. 2009 Jan; 58(1):39-45. Epub 2008 Oct 13. 1915534
    View PubMed
30. Man CD, Toffolo G, Basu R, Rizza RA, Cobelli C. Use of labeled oral minimal model to measure hepatic insulin sensitivity. Am J Physiol Endocrinol Metab. 2008 Nov; 295(5):E1152-9. Epub 2008 Sep 02. 1955242
    View PubMed
31. Lanza IR, Short DK, Short KR, Raghavakaimal S, Basu R, Joyner MJ, McConnell JP, Nair KS. Endurance exercise as a countermeasure for aging. Diabetes. 2008 Nov; 57(11):2933-42. Epub 2008 Aug 20. 1906855
    View PubMed
32. Basu R, Basu A, Chandramouli V, Norby B, Dicke B, Shah P, Cohen O, Landau BR, Rizza RA. Effects of pioglitazone and metformin on NEFA-induced insulin resistance in type 2 diabetes. Diabetologia. 2008 Nov; 51(11):2031-40. Epub 2008 Sep 04. 1909229
    View PubMed
33. Basu R, Chandramouli V, Dicke B, Landau BR, Rizza RA. Plasma C5 glucose-to-2H2O ratio does not provide an accurate assessment of gluconeogenesis during hyperinsulinemic-euglycemic clamps in either nondiabetic or diabetic humans. Diabetes. 2008 Jul; 57(7):1800-4. Epub 2008 Apr 16. 1892642
    View PubMed
34. Bock G, Schumann WC, Basu R, Burgess SC, Yan Z, Chandramouli V, Rizza RA, Landau BR. Evidence that processes other than gluconeogenesis may influence the ratio of deuterium on the fifth and third carbons of glucose: implications for the use of 2H2O to measure gluconeogenesis in humans. Diabetes. 2008 Jan; 57(1):50-5. Epub 2007 Oct 12. 1858543
    View PubMed
35. Basu R, Shah P, Basu A, Norby B, Dicke B, Chandramouli V, Cohen O, Landau BR, Rizza RA. Comparison of the effects of pioglitazone and metformin on hepatic and extra-hepatic insulin action in people with type 2 diabetes. Diabetes. 2008 Jan; 57(1):24-31. Epub 2007 Oct 03. 1858544
    View PubMed
36. Nelson RH, Basu R, Johnson CM, Rizza RA, Miles JM. Splanchnic spillover of extracellular lipase-generated fatty acids in overweight and obese humans. Diabetes. 2007 Dec; 56(12):2878-84. Epub 2007 Sep 19. 1853472
    View PubMed
37. Basu A, Charkoudian N, Schrage W, Rizza RA, Basu R, Joyner MJ. Beneficial effects of GLP-1 on endothelial function in humans: dampening by glyburide but not by glimepiride. Am J Physiol Endocrinol Metab. 2007 Nov; 293(5):E1289-95. Epub 2007 Aug 21. 1853504
    View PubMed
38. Butler AE, Galasso R, Meier JJ, Basu R, Rizza RA, Butler PC. Modestly increased beta cell apoptosis but no increased beta cell replication in recent-onset type 1 diabetic patients who died of diabetic ketoacidosis. Diabetologia. 2007 Nov; 50(11):2323-31. Epub 2007 Sep 06. 1844479
    View PubMed
39. Basu R, Dalla Man C, Campioni M, Basu A, Nair KS, Jensen MD, Khosla S, Klee G, Toffolo G, Cobelli C, Rizza RA. Effect of 2 years of testosterone replacement on insulin secretion, insulin action, glucose effectiveness, hepatic insulin clearance, and postprandial glucose turnover in elderly men. Diabetes Care. 2007 Aug; 30(8):1972-8. Epub 2007 May 11. 1841643
    View PubMed
40. Basu R, Pajvani UB, Rizza RA, Scherer PE. Selective downregulation of the high molecular weight form of adiponectin in hyperinsulinemia and in type 2 diabetes: differential regulation from nondiabetic subjects. Diabetes. 2007 Aug; 56(8):2174-7. Epub 2007 May 18. 1833046
    View PubMed
41. Nelson RH, Edgerton DS, Basu R, Roesner JC, Cherrington AD, Miles JM. Triglyceride uptake and lipoprotein lipase-generated fatty acid spillover in the splanchnic bed of dogs. Diabetes. 2007 Jul; 56(7):1850-5. Epub 2007 Apr 06. 1828152
    View PubMed
42. Gandhi GY, Basu R, Dispenzieri A, Basu A, Montori VM, Brennan MD. Endocrinopathy in POEMS syndrome: the Mayo Clinic experience. Mayo Clin Proc. 2007 Jul; 82(7):836-42. 1830818
    View PubMed
43. Bock G, Chittilapilly E, Basu R, Toffolo G, Cobelli C, Chandramouli V, Landau BR, Rizza RA. Contribution of hepatic and extrahepatic insulin resistance to the pathogenesis of impaired fasting glucose: role of increased rates of gluconeogenesis. Diabetes. 2007 Jun; 56(6):1703-11. 1822495
    View PubMed
44. Bock G, Dalla Man C, Campioni M, Chittilapilly E, Basu R, Toffolo G, Cobelli C, Rizza R. Effects of nonglucose nutrients on insulin secretion and action in people with pre-diabetes. Diabetes. 2007 Apr; 56(4):1113-9. 1820427
    View PubMed
45. Basu R, Dalla Man C, Campioni M, Basu A, Nair KS, Jensen MD, Khosla S, Klee G, Toffolo G, Cobelli C, Rizza RA. Two years of treatment with dehydroepiandrosterone does not improve insulin secretion, insulin action, or postprandial glucose turnover in elderly men or women. Diabetes. 2007 Mar; 56(3):753-66. 2210950
    View PubMed
46. Basu R, Dalla Man C, Campioni M, Basu A, Nair KS, Jensen M, Khosla S, Klee G, Toffolo G, Cobelli C, Rizza RA. Effects of two years of testosterone replacement on insulin secrection, insulin action, glucose effectiveness, hepatic insulin clearance and postprandial glucose turnover in elderly men Diabetes Care. 2007; 30:1972-78. 1923667
    
47. Bock G, Dalla Man C, Campioni M, Chittilapilly E, Basu R, Toffolo G, CobelliC, Rizza R. Effects of non-glucose nutrients on insulin secretion and action in people with pre-diabetes. Diabetes. 2007; 56:1113-9. 1923683
    
48. Cohen O, Basu R, Bock G, Dalla Man C, Campioni M, Basu A, Toffolo G, Cobelli C, Rizza RA. Prediction of postprandial glycemic exposure: utility of fasting and 2-h glucose measurements alone and in combination with assessment of body composition, fitness, and strength. Diabetes Care. 2006 Dec; 29(12):2708-13. 1794595
    View PubMed
49. Bock G, Dalla Man C, Campioni M, Chittilapilly E, Basu R, Toffolo G, Cobelli C, Rizza R. Pathogenesis of pre-diabetes: mechanisms of fasting and postprandial hyperglycemia in people with impaired fasting glucose and/or impaired glucose tolerance. Diabetes. 2006 Dec; 55(12):3536-49. 1794597
    View PubMed
50. Basu R, Edgerton DS, Singh RJ, Cherrington A, Rizza RA. Splanchnic cortisol production in dogs occurs primarily in the liver: evidence for substantial hepatic specific 11beta hydroxysteroid dehydrogenase type 1 activity. Diabetes. 2006 Nov; 55(11):3013-9. 1792886
    View PubMed
51. Nair KS, Rizza RA, O'Brien P, Dhatariya K, Short KR, Nehra A, Vittone JL, Klee GG, Basu A, Basu R, Cobelli C, Toffolo G, Dalla Man C, Tindall DJ, Melton LJ 3rd, Smith GE, Khosla S, Jensen MD. DHEA in elderly women and DHEA or testosterone in elderly men. N Engl J Med. 2006 Oct 19; 355(16):1647-59. 1787068
    View PubMed
52. Toffolo G, Basu R, Dalla Man C, Rizza R, Cobelli C. Assessment of postprandial glucose metabolism: conventional dual- vs. triple-tracer method. Am J Physiol Endocrinol Metab. 2006 Oct; 291(4):E800-6. Epub 2006 May 23. 1968670
    View PubMed
53. Basu R, Dalla Man C, Campioni M, Basu A, Klee G, Toffolo G, Cobelli C, Rizza RA. Effects of age and sex on postprandial glucose metabolism: differences in glucose turnover, insulin secretion, insulin action, and hepatic insulin extraction. Diabetes. 2006 Jul; 55(7):2001-14. 1775582
    View PubMed
54. Basu R, Singh R, Basu A, Johnson CM, Rizza RA. Effect of nutrient ingestion on total-body and splanchnic cortisol production in humans. Diabetes. 2006 Mar; 55(3):667-74. 1752264
    View PubMed
55. Toffolo G, Campioni M, Basu R, Rizza RA, Cobelli C. A minimal model of insulin secretion and kinetics to assess hepatic insulin extraction. Am J Physiol Endocrinol Metab. 2006 Jan; 290(1):E169-E176. Epub 2005 Sep 06. 1740272
    View PubMed
56. Dalla Man C, Toffolo G, Basu R, Rizza RA, Cobelli C. A model of glucose production during a meal. Conf Proc IEEE Eng Med Biol Soc. 2006; 1:5647-50. 1934767
    View PubMed
57. Dalla Man C, Caumo A, Basu R, Rizza R, Toffolo G, Cobelli C. Measurement of selective effect of insulin on glucose disposal from labeled glucose oral test minimal model. Am J Physiol Endocrinol Metab. 2005 Nov; 289(5):E909-14. 1732269
    View PubMed
58. Dalla Man C, Campioni M, Polonsky KS, Basu R, Rizza RA, Toffolo G, Cobelli C. Two-hour seven-sample oral glucose tolerance test and meal protocol - Minimal model assessment of beta-cell responsivity and insulin sensitivity in nondiabetic individuals. Diabetes. 2005 Nov; 54(11):3265-73. 1733862
    View PubMed
59. Basu R, Singh RJ, Basu A, Chittilapilly EG, Johnson MC, Toffolo G, Cobelli C, Rizza RA. Obesity and type 2 diabetes do not alter splanchnic cortisol production in humans. J Clin Endocrinol Metab. 2005 Jul; 90(7):3919-26. 1720467
    View PubMed
60. Basu R, Chandramouli V, Dicke B, Landau B, Rizza R. Obesity and type 2 diabetes impair insulin-induced suppression of glycogenolysis as well as gluconeogenesis. Diabetes. 2005 Jul; 54(7):1942-8. 1721435
    View PubMed
61. DPT Study Group - Type 1. Effects of oral insulin in relatives of patients with type 1 diabetes: The Diabetes Prevention Trial – Type 1. Diabetes Care. 2005; 28:1068-1076. 2182123
    
62. Moran A, Basu R, Milla C, Jensen MD. Insulin regulation of free fatty acid kinetics in adult cystic fibrosis patients with impaired glucose tolerance. Metabolism: Clinical & Experimental. 2004 Nov; 53(11):1467-72. 1674024
    View PubMed
63. Dalla Man C, Caumo A, Basu R, Rizza R, Toffolo G, Cobelli C. Minimal model estimation of glucose absorption and insulin sensitivity from oral test: validation with a tracer method. American Journal of Physiology - Endocrinology & Metabolism. 2004 Oct; 287(4):E637-43. 1663743
    View PubMed
64. Basu A, Shah P, Nielsen M, Basu R, Rizza RA. Effects of type 2 diabetes on the regulation of hepatic glucose metabolism. J Investig Med. 2004 Sep; 52(6):366-74. 1674509
    View PubMed
65. Basu R, Basu A, Johnson CM, Schwenk WF, Rizza RA. Insulin dose-response curves for stimulation of splanchnic glucose uptake and suppression of endogenous glucose production differ in nondiabetic humans and are abnormal in people with type 2 diabetes. Diabetes. 2004 Aug; 53(8):2042-50. 1657378
    View PubMed
66. Basu R, Singh RJ, Basu A, Chittilapilly EG, Johnson CM, Toffolo G, Cobelli C, Rizza RA. Splanchnic cortisol production occurs in humans: evidence for conversion of cortisone to cortisol via the 11-beta hydroxysteroid dehydrogenase (11beta-hsd) type 1 pathway. Diabetes. 2004 Aug; 53(8):2051-9. 1657379
    View PubMed
67. Basu R, Schwenk WF, Rizza RA. Both fasting glucose production and disappearance are abnormal in people with "mild" and "severe" type 2 diabetes. Am J Physiol Endocrinol Metab. 2004 Jul; 287(1):E55-62. Epub 2004 Feb 24. 1649288
    View PubMed
68. Adkins A, Basu R, Persson M, Dicke B, Shah P, Vella A, Schwenk WF, Rizza R. Higher insulin concentrations are required to suppress gluconeogenesis than glycogenolysis in nondiabetic humans. Diabetes. 2003 Sep; 52(9):2213-20. 1413610
    View PubMed
69. Zangeneh F, Basu R, Shah P, Arora P, Camilleri M, Rizza RA. Enteral infusion of glucose at rates approximating EGP enhances glucose disposal but does not cause hypoglycemia. Am J Physiol Endocrinol Metab. 2003 Aug; 285(2):E280-6. 1405115
    View PubMed
70. Vella A, Reed AS, Charkoudian N, Shah P, Basu R, Basu A, Joyner MJ, Rizza RA. Glucose-induced suppression of endogenous glucose production: dynamic response to differing glucose profiles. Am J Physiol Endocrinol Metab. 2003 Jul; 285(1):E25-30. Epub 2003 Mar 11. 1404247
    View PubMed
71. Basu R, Breda E, Oberg AL, Powell CC, Dalla Man C, Basu A, Vittone JL, Klee GG, Arora P, Jensen MD, Toffolo G, Cobelli C, Rizza RA. Mechanisms of the age-associated deterioration in glucose tolerance: contribution of alterations in insulin secretion, action, and clearance. Diabetes. 2003 Jul; 52(7):1738-48. 1404352
    View PubMed
72. Dispenzieri A, Kyle RA, Lacy MQ, Rajkumar SV, Therneau TM, Larson DR, Greipp PR, Witzig TE, Basu R, Suarez GA, Fonseca R, Lust JA, Gertz MA. POEMS syndrome: definitions and long-term outcome. Blood. 2003 Apr 1; 101(7):2496-506. 1328731
    View PubMed
73. Shah P, Vella A, Basu A, Basu R, Adkins A, Schwenk WF, Johnson CM, Nair KS, Jensen MD, Rizza RA. Elevated free fatty acids impair glucose metabolism in women: decreased stimulation of muscle glucose uptake and suppression of splanchnic glucose production during combined hyperinsulinemia and hyperglycemia. Diabetes. 2003 Jan; 52(1):38-42. 1317988
    View PubMed
74. Basu R, Di Camillo B, Toffolo G, Basu A, Shah P, Vella A, Rizza R, Cobelli C. Use of a novel triple-tracer approach to assess postprandial glucose metabolism. Am J Physiol Endocrinol Metab. 2003 Jan; 284(1):E55-69. 1317919
    View PubMed
75. Vella A, Shah P, Reed AS, Adkins AS, Basu R, Rizza RA. Lack of effect of exendin-4 and glucagon-like peptide-1-(7,36)-amide on insulin action in non-diabetic humans. Diabetologia. 2002 Oct; 45(10):1410-5. Epub 2002 Sep 05. 1316997
    View PubMed
76. Vella A, Shah P, Basu R, Basu A, Camilleri M, Schwenk WF, Rizza RA. Effect of enteral vs. parenteral glucose delivery on initial splanchnic glucose uptake in nondiabetic humans. Am J Physiol Endocrinol Metab. 2002 Aug; 283(2):E259-66. 1314813
    View PubMed
77. Shah P, Vella A, Basu A, Basu R, Adkins A, Schwenk WF, Johnson CM, Nair KS, Jensen MD, Rizza RA. Effects of free fatty acids and glycerol on splanchnic glucose metabolism and insulin extraction in nondiabetic humans. Diabetes. 2002 Feb; 51(2):301-10. 1008071
    View PubMed
78. DPT Study Group - Type 1. Effects of Insulin in Relatives of Patients with Type 1 Diabetes Mellitus. N Engl J Med. 2002; 346:1685-1691. 2182125
    
79. Basu R, Basu A, Nair KS. Muscle changes in aging. J Nutr Health Aging. 2002; 6(5):336-41. 1652514
    View PubMed
80. Basu A, Basu R, Shah P, Vella A, Rizza RA, Jensen MD. Systemic and regional free fatty acid metabolism in type 2 diabetes. Am J Physiol Endocrinol Metab. 2001 Jun; 280(6):E1000-6. 1005026
    View PubMed
81. Basu A, Basu R, Shah P, Vella A, Johnson CM, Jensen M, Nair KS, Schwenk WF, Rizza RA. Type 2 diabetes impairs splanchnic uptake of glucose but does not alter intestinal glucose absorption during enteral glucose feeding: additional evidence for a defect in hepatic glucokinase activity. Diabetes. 2001 Jun; 50(6):1351-62. 1005094
    View PubMed
82. Vella A, Shah P, Basu R, Basu A, Camilleri M, Schwenk WF, Rizza RA. Type I diabetes mellitus does not alter initial splanchnic glucose extraction or hepatic UDP-glucose flux during enteral glucose administration. Diabetologia. 2001 Jun; 44(6):729-37. 1004513
    View PubMed
83. Vella A, Shah P, Basu R, Basu A, Camilleri M, Schwenk FW, Holst JJ, Rizza RA. Effect of glucagon-like peptide-1(7-36)-amide on initial splanchnic glucose uptake and insulin action in humans with type 1 diabetes. Diabetes. 2001 Mar; 50(3):565-72. 1003674
    View PubMed
84. Shah P, Vella A, Basu A, Basu R, Schwenk WF, Rizza RA. Lack of suppression of glucagon contributes to postprandial hyperglycemia in subjects with type 2 diabetes mellitus. J Clin Endocrinol Metab. 2000 Nov; 85(11):4053-9. 1014052
    View PubMed
85. Vella A, Shah P, Basu R, Basu A, Holst JJ, Rizza RA. Effect of glucagon-like peptide 1(7-36) amide on glucose effectiveness and insulin action in people with type 2 diabetes. Diabetes. 2000 Apr; 49(4):611-7. 131603
    View PubMed
86. Basu A, Basu R, Shah P, Vella A, Johnson CM, Nair KS, Jensen MD, Schwenk WF, Rizza RA. Effects of type 2 diabetes on the ability of insulin and glucose to regulate splanchnic and muscle glucose metabolism: evidence for a defect in hepatic glucokinase activity. Diabetes. 2000 Feb; 49(2):272-83. 128316
    View PubMed
87. Shah P, Basu A, Basu R, Rizza R. Impact of lack of suppression of glucagon on glucose tolerance in humans. Am J Physiol. 1999 Aug; 277(2 Pt 1):E283-90. 1008943
    View PubMed
88. Basu R, Basu A, Nielsen M, Shah P, Rizza RA. Effect of overnight restoration of euglycemia on glucose effectiveness in type 2 diabetes mellitus. J Clin Endocrinol Metab. 1999 Jul; 84(7):2314-9. 1008709
    View PubMed
89. Nielsen MF, Basu R, Wise S, Caumo A, Cobelli C, Rizza RA. Normal glucose-induced suppression of glucose production but impaired stimulation of glucose disposal in type 2 diabetes: evidence for a concentration-dependent defect in uptake. Diabetes. 1998 Nov; 47(11):1735-47. 1019080
    View PubMed
90. Nielsen MF, Dinneen S, Basu A, Basu R, Alzaid A, Rizza RR. Failure of nocturnal changes in growth hormone to alter carbohydrate tolerance the following morning. Diabetologia. 1998 Sep; 41(9):1064-72. 107910
    View PubMed